Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Stakeholders Involved in the Innovation Process
Future Perspectives
PESTEL Analysis
Porter’s Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Drug Manufacturing
QC and Compliance
Distribution
Regulatory Approval and Pricing Constraints
Sales and Marketing
Reverse Logistics and Returns

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Healthcare Expenditures
Focus on Rare Diseases and Orphan Drugs
Increasing Prevalence of Chronic Diseases and Aging Populations
Market Restraints
Stringent Regulatory Concerns
Loss of Exclusivity and Genericization
Lack of Oncology Professionals
Market Opportunities
Focus on Health Equity and Accessibility
AI in Oncology
Emerging Markets
Market Challenges
Price Pressures and Market Access
Environmental Impact and Sustainability
Counterfeit Drugs

Chapter 4 Regulatory Landscape
Regulatory Framework
Regulatory Systems for Biopharmaceuticals
U.S.
Europe
Japan
Regulatory Systems for Pharmaceuticals
U.S.
EU Approval Process
Japan Approval Process
India Approval Process
Brazil Approval Process
GMP Compliance
Establishment Registration
Drug Registration and Listing
Local Agent Requirements
Responsibilities of the U.S. Agent

Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Artificial Intelligence (AI) and Machine Learning (ML)
Nanotechnology
3D Printing
Patent Analysis
Takeaways

Chapter 6 Sustainability in the Pharmaceutical Drug Industry: An ESG Perspective
Sustainability in the Pharmaceutical Drugs Industry
Environmental
Social
Governance
Understanding ESG Data

Chapter 7 Competitive Intelligence
Overview
Global Market Shares of Pharmaceutical Drug Companies
Strategies of Major Pharmaceutical Drug Manufacturers
Distribution Networks

Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
ABBVIE INC.
ALNYLAM PHARMACEUTICALS INC.
AMGEN INC.
ARGENX
ASTELLAS PHARMA INC.
ASTRAZENECA
AUROBINDO PHARMA LTD.
BAUSCH HEALTH COMPANIES INC.
BAXTER
BAYER AG
BIOCON
BIOGEN
BIOMARIN
BIONTECH SE
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
CHUGAI PHARMACEUTICAL CO. LTD.
CSL
CSPC PHARMACEUTICAL GROUP LTD.
DAIICHI SANKYO CO. LTD.
DIVI’S LABORATORIES LTD.
EISAI CO. LTD.
F. HOFFMANN-LA ROCHE LTD.
GALDERMA
GILEAD SCIENCES INC.
GRIFOLS S.A.
GSK PLC.
H. LUNDBECK A/S
INCYTE
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON SERVICES INC.
LES LABORATOIRES SERVIER
LILLY
MERCK & CO. INC.
MERCK KGAA
MODERNA INC.
NEUROCRINE BIOSCIENCES INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
SANOFI
SINO BIOPHARMACEUTICAL CO. LTD.
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
Emerging Players in the Market



List of Figures

 

Summary Figure : Global Market Shares of Pharmaceutical Drugs, by Region, 2023
Figure 1 : Supply Chain of the Pharmaceutical Drugs Industry
Figure 2 : Pharmaceutical Drug Industry Market Dynamics
Figure 3 : Trends and Emerging Technologies in the Pharmaceutical Drug Industry
Figure 4 : Global Market Shares of Leading Pharmaceutical Drug Companies, 2023
Figure 5 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 6 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 7 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2023
Figure 8 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2023
Figure 9 : Alnylam Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 10 : Alnylam Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 11 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 12 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 13 : Argenx: Revenue Share, by Country/Region, FY 2023
Figure 14 : Astellas Pharma Inc.: Revenue Share, by Business Unit, FY 2023
Figure 15 : Astellas Pharma Inc.: Revenue Share, by Country/Region, FY 2023
Figure 16 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 17 : AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 18 : Aurobindo Pharma Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 19 : Aurobindo Pharma Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 20 : Bausch Health Companies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 21 : Bausch Health Companies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 22 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 23 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 24 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 25 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 26 : Biocon: Revenue Share, by Business Unit, FY 2023
Figure 27 : Biogen: Revenue Share, by Business Unit, FY 2023
Figure 28 : Biogen: Revenue Share, by Country/Region, FY 2023
Figure 29 : BioMarin: Revenue Share, by Business Unit, FY 2023
Figure 30 : BioMarin: Revenue Share, by Country/Region, FY 2023
Figure 31 : BioNTech SE: Revenue Share, by Business Unit, FY 2023
Figure 32 : Boehringer Ingelheim International GmbH: Revenue Share, by Business Unit, FY 2023
Figure 33 : Boehringer Ingelheim International GmbH: Revenue Share, by Region/Country, FY 2023
Figure 34 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Chugai Pharmaceutical Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 37 : CSL: Revenue Share, by Business Unit, FY 2023
Figure 38 : CSL: Revenue Share, by Region, FY 2023
Figure 39 : CSPC Pharmaceutical Group Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 40 : CSPC Pharmaceutical Group Ltd.: Revenue Share, by Region, FY 2023
Figure 41 : Daiichi Sankyo Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Daiichi Sankyo Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 43 : Divi’s Laboratories Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 44 : Eisai Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 45 : Eisai Co. Ltd.: Revenue Share, by Region/Country, FY 2023
Figure 46 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 47 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 48 : Galderma: Revenue Share, by Business Unit, FY 2023
Figure 49 : Galderma: Revenue Share, by Country/Region, FY 2023
Figure 50 : Gilead Sciences Inc.: Revenue Share, by Business Unit, FY 2023
Figure 51 : Gilead Sciences Inc.: Revenue Share, by Country/Region, FY 2023
Figure 52 : Grifols S.A: Revenue Share, by Business Unit, FY 2023
Figure 53 : Grifols S.A.: Revenue Share, by Region, FY 2023
Figure 54 : GSK plc.: Revenue Share, by Business Unit, FY 2023
Figure 55 : GSK plc.: Revenue Share, by Country/Region, FY 2023
Figure 56 : H. Lundbeck A/S: Revenue Share, by Business Unit, FY 2023
Figure 57 : H. Lundbeck A/S: Revenue Share, by Country/Region, FY 2023
Figure 58 : Incyte: Revenue Share, by Business Unit, FY 2023
Figure 59 : Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 60 : Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 61 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 62 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 63 : Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
Figure 64 : Les Laboratoires Servier: Revenue Share, by Region, FY 2023
Figure 65 : Lilly: Revenue Share, by Business Unit, FY 2023
Figure 66 : Lilly: Revenue Share, by Country/Region, FY 2023
Figure 67 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 68 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 69 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 70 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 71 : Moderna Inc.: Revenue Share, by Country/Region, FY 2023
Figure 72 : Neurocrine Biosciences Inc: Revenue Share, by Business Unit, FY 2023
Figure 73 : Novartis AG: Revenue Share, by Business Unit, FY 2023
Figure 74 : Novartis AG: Revenue Share, by Country/Region, FY 2023
Figure 75 : Novo Nordisk A/S: Revenue Share, by Business Unit, FY 2023
Figure 76 : Novo Nordisk A/S: Revenue Share, by Country/Region, FY 2023
Figure 77 : Otsuka Holdings Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 78 : Otsuka Holdings Co. Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 79 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 80 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 81 : Regeneron Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 82 : Regeneron Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 83 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 84 : Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 85 : Sino Biopharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 86 : Sino Biopharmaceutical Co. Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 87 : Sun Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 88 : Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 89 : Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 90 : Teva Pharmaceutical Industries Ltd: Revenue Share, by Business Unit, FY 2023
Figure 91 : Teva Pharmaceutical Industries Ltd: Revenue Share, by Country/Region, FY 2023
Figure 92 : Vertex Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 93 : Vertex Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 94 : Viatris Inc.: Revenue Share, by Business Unit, FY 2023
Figure 95 : Viatris Inc.: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for Pharmaceutical Drugs, by Region, Through 2029
Table 1 : Global Health Expenditures, by Country, 2022
Table 2 : Global Incidence of All Cancers, by WHO Region, 2022–2050
Table 3 : Pharmaceutical Drug Patents Granted, by Leading Applicant, 2023
Table 4 : Pharmaceutical Drug Patents Granted, by Assignee Country/Region, January 2023–January 2025
Table 5 : ESG Rankings for Pharmaceutical Companies
Table 6 : Global Market Shares of Pharmaceutical Drugs, by Company, 2023
Table 7 : Best-Selling Pharmaceuticals, 2023
Table 8 : Total Revenue, Pharmaceutical Revenue, R&D Expenditure and Percentage of R&D in Revenue, by Drug Manufacturer, 2023
Table 9 : Abbreviations Used in this Report
Table 10 : Information Sources Used for this Report
Table 11 : Abbott: Company Snapshot
Table 12 : Abbott: Financial Performance, FY 2022 and 2023
Table 13 : Abbott: Product Portfolio
Table 14 : AbbVie Inc.: Company Snapshot
Table 15 : AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 16 : AbbVie Inc.: Product Portfolio
Table 17 : AbbVie Inc.: News/Key Developments, 2023-2025
Table 18 : Alnylam Pharmaceuticals Inc.: Company Snapshot
Table 19 : Alnylam Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 20 : Alnylam Pharmaceuticals Inc.: Product Portfolio
Table 21 : Alnylam Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 22 : Amgen Inc.: Company Snapshot
Table 23 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 24 : Amgen Inc.: Product Portfolio
Table 25 : Amgen Inc.: News/Key Developments, 2023-2025
Table 26 : Argenx: Company Snapshot
Table 27 : Argenx: Financial Performance, FY 2022 and 2023
Table 28 : Argenx: Product Portfolio
Table 29 : Argenx: News/Key Developments, 2023 and 2024
Table 30 : Astellas Pharma Inc.: Company Snapshot
Table 31 : Astellas Pharma Inc: Financial Performance, FY 2022 and 2023
Table 32 : Astellas Pharma Inc.: Product Portfolio
Table 33 : Astellas Pharma Inc.: News/Key Developments, 2023-2025
Table 34 : AstraZeneca: Company Snapshot
Table 35 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 36 : AstraZeneca: Product Portfolio
Table 37 : AstraZeneca: News/Recent Developments, 2023?2025
Table 38 : Aurobindo Pharma Ltd.: Company Snapshot
Table 39 : Aurobindo Pharma Ltd.: Financial Performance, FY 2022 and 2023
Table 40 : Aurobindo Pharma Ltd.: Product Portfolio
Table 41 : Aurobindo Pharma Ltd.: News/Key Developments, 2023 and 2024
Table 42 : Bausch Health Companies Inc.: Company Snapshot
Table 43 : Bausch Health Companies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Bausch Health Companies Inc.: Product Portfolio
Table 45 : Bausch Health Companies Inc.: News/Key Developments, 2023
Table 46 : Baxter: Company Snapshot
Table 47 : Baxter: Financial Performance, FY 2022 and 2023
Table 48 : Baxter: Product Portfolio
Table 49 : Baxter: News/Key Developments, 2023 and 2024
Table 50 : Bayer AG: Company Snapshot
Table 51 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 52 : Bayer AG: Product Portfolio
Table 53 : Bayer AG: News/Key Developments, 2023-2025
Table 54 : Biocon: Company Snapshot
Table 55 : Biocon: Financial Performance, FY 2022 and 2023
Table 56 : Biocon: Product Portfolio
Table 57 : Biocon: News/Key Developments, 2023-2024
Table 58 : Biogen: Company Snapshot
Table 59 : Biogen: Financial Performance, FY 2022 and 2023
Table 60 : Biogen: Product Portfolio
Table 61 : Biogen: News/Key Developments, 2023-2025
Table 62 : BioMarin: Company Snapshot
Table 63 : BioMarin: Financial Performance, FY 2022 and 2023
Table 64 : BioMarin: Product Portfolio
Table 65 : BioMarin: News/Key Developments, 2021-2024
Table 66 : BioNTech SE: Company Snapshot
Table 67 : BioNTech SE: Financial Performance, FY 2022 and 2023
Table 68 : BioNTech SE: Product Portfolio
Table 69 : BioNTech: News/Key Developments, 2023-2025
Table 70 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 71 : Boehringer Ingelheim International GmbH: Financial Performance, FY 2022 and 2023
Table 72 : Boehringer Ingelheim International GmbH: Product Portfolio
Table 73 : Boehringer Ingelheim International GmbH: News/Key Developments, 2023-2025
Table 74 : Bristol-Myers Squibb Co.: Company Snapshot
Table 75 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 76 : Bristol-Myers Squibb Co.: Product Portfolio
Table 77 : Bristol-Myers Squibb Co.: News/Key Developments, 2023 and 2024
Table 78 : Chugai Pharmaceutical Co. Ltd.: Company Snapshot
Table 79 : Chugai Pharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 80 : Chugai Pharmaceutical Co. Ltd.: Product Portfolio
Table 81 : Chugai Pharmaceutical Co. Ltd: News/Key Developments, 2023-2025
Table 82 : CSL: Company Snapshot
Table 83 : CSL: Financial Performance, FY 2022 and 2023
Table 84 : CSL: Product Portfolio
Table 85 : CSL: News/Key Developments, 2023-2025
Table 86 : CSPC Pharmaceutical Group Ltd.: Company Snapshot
Table 87 : CSPC Pharmaceutical Group Ltd.: Financial Performance, FY 2022 and 2023
Table 88 : CSPC Pharmaceutical Group Ltd.: Product Portfolio
Table 89 : CSPC Pharmaceutical Group Ltd.: News/Key Developments, 2024
Table 90 : Daiichi Sankyo Co. Ltd.: Company Snapshot
Table 91 : Daiichi Sankyo Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 92 : Daiichi Sankyo Co. Ltd.: Product Portfolio
Table 93 : Daiichi Sankyo Co. Ltd.: News/Key Developments, 2022-2025
Table 94 : Divi’s Laboratories Ltd.: Company Snapshot
Table 95 : Divi’s Laboratories Ltd.: Financial Performance, FY 2022 and 2023
Table 96 : Divi’s Laboratories Ltd.: Product Portfolio
Table 97 : Eisai Co. Ltd.: Company Snapshot
Table 98 : Eisai Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 99 : Eisai Co. Ltd.: Product Portfolio
Table 100 : Eisai Co. Ltd.: News/Recent Developments, 2023-2025
Table 101 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 102 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 103 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 104 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023–2025
Table 105 : Galderma: Company Snapshot
Table 106 : Galderma: Financial Performance, FY 2022 and 2023
Table 107 : Galderma: Product Portfolio
Table 108 : Galderma: News/Key Developments, 2024
Table 109 : Gilead Sciences Inc.: Company Snapshot
Table 110 : Gilead Sciences Inc.: Financial Performance, FY 2022 and 2023
Table 111 : Gilead Sciences Inc.: Product Portfolio
Table 112 : Gilead Sciences Inc.: News/Key Developments, 2023–2025
Table 113 : Grifols S.A: Company Snapshot
Table 114 : Grifols S.A.: Financial Performance, FY 2022 and 2023
Table 115 : Grifols S.A: Product Portfolio
Table 116 : Grifols S.A: News/Key Developments, 2023-2025
Table 117 : GSK plc.: Company Snapshot
Table 118 : GSK plc.: Financial Performance, FY 2022 and 2023
Table 119 : GSK plc.: Product Portfolio
Table 120 : GSK plc.: News/Key Developments, 2023–2025
Table 121 : H. Lundbeck A/S: Company Snapshot
Table 122 : H. Lundbeck A/S: Financial Performance, FY 2022 and 2023
Table 123 : H. Lundbeck A/S: Product Portfolio
Table 124 : H. Lundbeck A/S: News/Key Developments, 2022-2024
Table 125 : Incyte: Company Snapshot
Table 126 : Incyte: Financial Performance, FY 2022 and 2023
Table 127 : Incyte: Product Portfolio
Table 128 : Incyte: News/Key Developments, 2023-2025
Table 129 : Jazz Pharmaceuticals Inc.: Company Snapshot
Table 130 : Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 131 : Jazz Pharmaceuticals Inc.: Product Portfolio
Table 132 : Jazz Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 133 : Johnson & Johnson Services Inc.: Company Snapshot
Table 134 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 135 : Johnson & Johnson Services Inc.: Product Portfolio
Table 136 : Johnson & Johnson Services Inc.: News/Key Developments, 2022?2024
Table 137 : Les Laboratoires Servier: Company Snapshot
Table 138 : Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
Table 139 : Les Laboratoires Servier: Product Portfolio
Table 140 : Les Laboratoires Servier: News/Key Developments, 2023-2025
Table 141 : Lilly: Company Snapshot
Table 142 : Lilly: Financial Performance, FY 2022 and 2023
Table 143 : Lilly: Product Portfolio
Table 144 : Lilly: News/Key Developments, 2022–2025
Table 145 : Merck & Co. Inc.: Company Snapshot
Table 146 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 147 : Merck & Co. Inc.: Product Portfolio
Table 148 : Merck & Co. Inc.: News/Key Developments, 2021–2024
Table 149 : Merck KGaA: Company Snapshot
Table 150 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 151 : Merck KGaA: Product Portfolio
Table 152 : Merck KGaA: News/Key Developments, 2023-2025
Table 153 : Moderna Inc.: Company Snapshot
Table 154 : Moderna Inc.: Financial Performance, FY 2022 and 2023
Table 155 : Moderna Inc.: Product Portfolio
Table 156 : Moderna Inc.: News/Key Developments, 2023 and 2024
Table 157 : Neurocrine Biosciences Inc: Company Snapshot
Table 158 : Neurocrine Biosciences Inc: Financial Performance, FY 2022 and 2023
Table 159 : Neurocrine Biosciences Inc: Product Portfolio
Table 160 : Neurocrine Biosciences Inc: News/Key Developments, 2023-2025
Table 161 : Novartis AG: Company Snapshot
Table 162 : Novartis AG: Financial Performance, FY 2022 and 2023
Table 163 : Novartis AG: Product Portfolio
Table 164 : Novartis AG: News/Key Developments, 2022-2024
Table 165 : Novo Nordisk A/S: Company Snapshot
Table 166 : Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
Table 167 : Novo Nordisk A/S: Product Portfolio
Table 168 : Novo Nordisk A/S: News/Key Developments, 2023-2025
Table 169 : Otsuka Holdings Co. Ltd.: Company Snapshot
Table 170 : Otsuka Holdings Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 171 : Otsuka Holdings Co. Ltd.: Product Portfolio
Table 172 : Otsuka Holdings Co. Ltd.: News/Key Developments, 2023 and 2024
Table 173 : Pfizer Inc.: Company Snapshot
Table 174 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 175 : Pfizer Inc.: Product Portfolio
Table 176 : Pfizer Inc.: News/Key Developments, 2023 and 2024
Table 177 : Regeneron Pharmaceuticals Inc.: Company Snapshot
Table 178 : Regeneron Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 179 : Regeneron Pharmaceuticals Inc.: Product Portfolio
Table 180 : Regeneron Pharmaceuticals Inc.: News/Key Developments, 2022-2024
Table 181 : Sanofi: Company Snapshot
Table 182 : Sanofi: Financial Performance, FY 2022 and 2023
Table 183 : Sanofi: Product Portfolio
Table 184 : Sanofi: News/Key Developments, 2022–2025
Table 185 : Sino Biopharmaceutical Co. Ltd.: Company Snapshot
Table 186 : Sino Biopharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 187 : Sino Biopharmaceutical Co. Ltd.: Product Portfolio
Table 188 : Sino Biopharmaceutical Co. Ltd.: News/Key Developments, 2023-2025
Table 189 : Sun Pharmaceutical Industries Ltd.: Company Snapshot
Table 190 : Sun Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 191 : Sun Pharmaceutical Industries Ltd.: Product Portfolio
Table 192 : Sun Pharmaceutical Industries Ltd.: News/Key Developments, 2022-2024
Table 193 : Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 194 : Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 195 : Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 196 : Takeda Pharmaceutical Co. Ltd.: News/Key Developments, 2023 and 2024
Table 197 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 198 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 199 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 200 : Vertex Pharmaceuticals Inc.: Company Snapshot
Table 201 : Vertex Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 202 : Vertex Pharmaceuticals Inc.: Product Portfolio
Table 203 : Vertex Pharmaceuticals Inc.: News/Key Developments, 2022-2025
Table 204 : Viatris Inc.: Company Snapshot
Table 205 : Viatris Inc.: Financial Performance, FY 2022 and 2023
Table 206 : Viatris Inc.: Product Portfolio
Table 207 : Viatris Inc.: News/Key Developments, 2023 and 2024
Table 208 : Few Emerging Players in the Market